Before the bell.
Beyond the headline.

Futures rebound, Marriott raises its outlook, and execution risks reshape Alstom and Karyopharm.

01 / The market setup

U.S. equity futures pointed higher before the opening bell. At 8:50 a.m. Eastern, Reuters reported:

These are premarket futures changes, not cash-index returns. Reuters linked the rebound to falling oil prices and hopes for progress in Middle East negotiations.

Editorial context: Today’s company news tests two sides of the investment cycle: confidence sufficient to support a major acquisition, and the operating discipline required to turn demand into earnings.

Hunter’s Insight

A useful distinction this morning is between demand for a technology and the return earned on the capital behind it. Marvell’s proposed combination with Lumentum is a large commitment to AI connectivity; its projected synergies still have to become operating results. Marriott and Alstom offer a parallel lesson: demand matters, but delivery determines how much reaches the bottom line. Today’s task is to separate signed agreements from completed transactions, guidance from reported earnings, and strategic ambition from cash generation. A rising futures market does not settle any of those questions.

02 / Five stories that matter

1. Marvell agrees to acquire Lumentum — MRVL, LITE

The companies announced an all-stock agreement with an implied enterprise value of $115 billion. Lumentum holders would receive 4.500 Marvell shares per share. Closing is expected in the first half of 2028, subject to shareholder and regulatory approvals. Management projects more than $1 billion in annual run-rate cost synergies.

What to watch: Integration, customer commitments and whether projected savings materialize. The announced valuation is transaction consideration, not a current trading quote.

2. Marriott raises its outlook — MAR

Marriott reported third-quarter worldwide revenue-per-available-room growth of 6.5%, with U.S. and Canada growth of 7.4%. Reported net income was $794 million, or $3.04 per diluted share. The company now expects full-year worldwide RevPAR growth of 4.5%–5%.

What to watch: Whether higher room revenue and additional properties continue translating into fee growth. The annual range remains guidance.

3. Alstom cuts its profitability target — ALO.PA

Alstom’s preliminary, unaudited first-half update reported €9.3 billion in sales and an adjusted EBIT margin around negative 4%. It cut its fiscal 2026/27 margin forecast to approximately 1%, from 6.5%, and now projects €1.5 billion in free cash outflow.

What to watch: Coradia Max execution, approval timelines and milestone payments. Sales growth has not prevented deterioration in profitability and cash generation.

4. Karyopharm begins a court-supervised restructuring — KPTI

Karyopharm filed voluntary Chapter 11 petitions and outlined a planned combination with Ayrmid through a reorganization plan. Existing secured lenders committed up to $55 million in debtor-in-possession financing, subject to court approval. Competing bids may be submitted; closing is expected in first-quarter 2027, subject to conditions.

What to watch: Court decisions, financing approval and competing proposals. This is a proposed restructuring transaction, not a completed merger.

5. BP completes the Castrol transaction — BP

BP completed the sale of 65% of Castrol to Stonepeak, retaining a 35% interest. Reuters reported that BP intends to use $6 billion in after-tax proceeds to reduce debt and strengthen its finances.

What to watch: How the cash proceeds affect BP’s balance sheet and subsequent capital-allocation decisions. Unlike the other proposed transactions above, this sale has closed.

03 / Company in focus — Apple / AAPL

Apple’s earnings arrive after the close, with its conference call scheduled for 5:00 p.m. Eastern. MacRumors’ report, citing Apple’s investor-relations announcement, places the results release at 4:30 p.m. Eastern.

The research questions: How are product demand and component costs affecting margins? What does management disclose about the holiday quarter? Keep reported September-quarter performance separate from expectations for products shipping afterward. These are questions for the release and call, not conclusions about results that have yet to be announced.

04 / Today’s catalysts — all times Eastern

Economic times come from the New York Fed calendar. Apple timing is attributed above; Palantir’s schedule comes from its investor-relations announcement. Schedules can change.

The Equity Dispatch · A Spencer Pruitt publication

Reporting is attributed to linked sources; Hunter’s Insight and editorial context are commentary. For information only. Not investment advice.

All approved editions ↗